SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Sep 28, 2018

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Sept. 28, 2018 · CIK: 0001585608 · Accession: 0001104659-18-059410

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227292

Date
September 28, 2018
Author
H.C. WAINWRIGHT & CO., LLC
Form
CORRESP
Company
Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

Re:

September 28, 2018

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

JAGUAR HEALTH, INC.

Registration Statement on Form S-1 (Registration No. 333-227292)

Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the above-referenced offering, hereby concurs in the request by Jaguar Health, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Monday, October 1, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text
CORRESP
1
filename1.htm

September 28, 2018

VIA FACSIMILE AND EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C.  20549

Re:

JAGUAR HEALTH, INC.

Registration Statement on   Form S-1 (Registration No. 333-227292)

Concurrence in Acceleration   Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“Wainwright”), as underwriter for the above-referenced offering, hereby concurs in the request by Jaguar Health, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Monday, October 1, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act.  Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.

Very truly yours,

H.C. WAINWRIGHT & CO.,   LLC

By:

/s/ Mark Viklund

Name: Mark Viklund

Title: Chief Executive   Officer

430 Park Avenue | New York, New York 10022 | 212.356.0500

Security services provided by H.C. Wainwright & Co., LLC | Member: FINRA/SIPC